Approval · Notice of Compliance 5261 · 1995

PROGRAF: Notice of Compliance 5261

Issued December 6, 1995

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 5261
Date: December 6, 1995
Company: Fujisawa Canada Inc.Markham, Ontario, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Priority-NAS
Therapeutic class: Immunosuppressant

Products in this notice

Brand	DIN	Status today
PROGRAF	02175991	Marketed
PROGRAF	02175983	Marketed
PROGRAF	02176009	Marketed

Medicinal ingredients

TACROLIMUS 1 MG per CAP
TACROLIMUS 5 MG per CAP
TACROLIMUS 5 MG per ML